SUMMARY Absorption of cobalamin free or bound to chicken serum was assessed in nine patients with pancreatic insufficiency. Simultaneously the in vitro effect of duodenal juice collected from six patients and seven controls was tested on labelled cobalamin complexed to chicken serum or to R salivary binder. Malabsorption of free cobalamin was observed in one of nine patients and in four of nine patients when cobalamin was administered bound to chicken serum. The in vitro effect of duodenal juice on cobalamin complexed to chicken serum or to R salivary binder was studied: (a) the percentage of free cobalamin released was significantly decreased in pancreatic insufficiency compared with controls whatever the binder used; (b) the degradation of R salivary binder was different in pancreatic insufficiency and in controls. Despite the in vitro abnormalities observed in pancreatic insufficiency, these did not correlate with the in vivo absorption of cobalamin which was often normal in our patients.
The exact pathogenesis of cobalamin malabsorption in patients with chronic pancreatitis has not been completely clarified, despite intensive investigations in this field. Most authors consider this malabsorption to be directly related to a defect in the external pancreatic secretion which would be responsible for inadequate degradation of R binders to which cobalamin are bound in gastric juice. conditions, different proteases essentially trypsin, degrade R binders and liberate free cobalamin which subsequently complexes to intrinsic factor, unaffected by these enzymes.2 Several studies in vivo35 and in vitro2 6 have shown that in pancreatic insufficiency, R proteins failed to be degraded and sequestered a major fraction of cobalamin and this explained the malabsorption. To this effect, differential absorption of cobalamin bound to intrinsic factor and R proteins was studied using a dual label Schilling test.7 Cobalamin malabsorption is not a constant feature in patients with pancreatic insufficiency.!"') Furthermore, correlation between the in vitro undegraded R proteins and the in vivo cobalamin absorption has not been fully assessed in these patients. Therefore, we have studied simultaneously in the same patients suffering with pancreatic insufficiency the in vitro effect of duodenal juice on two cobalamin binding proteins (chicken serum and saliva) and the absorption of free cobalamin and cobalamin bound to chicken serum. The column was first calibrated with blue dextran to determine the void volume and with albumin, y-globulins and lysozyme. The molecular weight of chicken serum was assessed by gel chromatography in the same conditions as above and compared with that of saliva, bile, and gastric juice. Immunological reactivity of this binder was tested against an antihuman serum R binder antibody, after incubation with this antiserum and chromatography on Ultrogel.
Methods

ANAL YSIS OF GASTRIC SECRETIONS
This was carried out in patients with pancreatic disease in basal conditions and after pentagastrin stimulation (6 kg/kg). Hlydrogen ion concentration in gastric juice was measured by titration to p1-1=7.0 with 0-1 N NaOH. Basal acid output and stimulated acid output were calculated. The concentration of intrinsic factor in gastric juice was measured by the method of Gottlieb et al. 14 Cobalamin malabsorption was observed in one patient when the test was done with free cobalamin and in four patients with cobalamin bound to chicken serum (Table 1 ). The patient with the most important steatorrhea was the only one that had a combined abnormal absorption of both forms.
In the in vitro effect of duodenal j uice on cobalamin bound to chicken serum and saliva preliminary studies on the characterisation of the cobalamin binder from chicken serum showed that this binder had an apparent molecular weight of 120 000. This molecular weight was similar to that of salivary, biliary, gastric juice R binders (Figure) . In addition, the incubation of (97Co) cyanocobalamin bound to chicken serum with an anti-R binder antiserum gave on gel filtration a peak with a larger molecular weight eluted with the void volume, corresponding to an immune complex.
Incubation of chicken serum binder cobalamin complex with duodenal juice from controls induced a release of free cobalamin (median: 1-73% of total radioactivity with a range from 1.5-2.2). This release was significantly lower (p<0-01) when the complex was incubated with duodenal juice originating from patients with pancreatic insufficiency (median: 0-70 ranging from 0-55-0 90) ( Table 2 ). The dissociation of the complex was also significantly decreased when duodenal juice from controls 105- (cpm) Belaiche, Zittoun, Marquet, Yvart, and Cattan was collected on aprotinin (p<0.01). There was no apparent degradation of the chicken serum binder after incubation with duodenal juice; gel filtration on AcA34 gave identical molecular weight fragments; gel filtration on AcA54 which gives a finer resolution for smaller molecular weight species did not identify any cobalamin binding cleavage products. Incubation of chicken serum with trypsin alone gave results similar to those obtained with normal duodenal juice: R binder and release of free cobalamin in the same proportions.
Incubation of salivary R binder-cobalamin complex with duodenal juice from controls produced a Table 3 Release of degraded fragments with various molecular weights (MW) and offree cobalamin (cbl) from cbl-R saliva after incubation with duodenal juice. Results are expressed in % of the total radioactivity.
Degraded salivary R-binder25 000 Subject (n) 60 000 MW to 50 000 MW In vitro effect of duodenal juice on R binders cobalamin complexes degraded fragment of 60 000 molecular weight and cobalamin; no intact R binder was identified (Table  3) . Duodenal juice from patients with pancreatic insufficiency incubated with salivary R binder cobalamin showed heterogeneous patterns of degradation. R binder was also degraded either in fragments of 60 000 molecular weight in some patients or in even smaller fragments ranging from 25 000 to 50 000 in other patients. Cobalamin was also released in all patients but in lower proportions than in controls (p<0.05). Samples of duodenal juice from controls collected on aprotinin induced a poor release of free cobalamin significantly lower than samples without aprotinin (p<0-01). The major part of the radioactivity was shared between the R binder and the fragment of 60 000 molecular weight when the collection of samples was made on aprotinin.
The action of trypsin on cobalamin bound to saliva was stronger than that of duodenal juice: after four hours of incubation, only cobalamin was identified; whereas on shorter times of incubation the degraded fragment of 60 000 molecular weight was observed concommitant of a release of cobalamin.
Discussion
A malabsorption of free cobalamin was observed in one of the nine patients studied. This frequency is lower than that observed in other series, the incidence of malabsorption rating an average 46% .>"' The percentage of malabsorption increased when we assessed the absorption of cobalamin bound to chicken serum (four of nine patients). Another comparative study using cobalamin bound to the R salivary protein failed to show a malabsorption in 11 patients with chronic pancreatitis. '5 Cobalamin malabsorption possibly related to pernicious anaemia or gastric achlorhydria'3 has been excluded because all our patients had normal intrinsic factor output and normal gastric acid secretion.
Our in vitro studies showed that duodenal juice from normal subjects induced modifications of cobalamin complexed to chicken serum or to saliva as did those from patients with pancreatic insufficiency. In fact, the cobalamin binding protein present in chicken serum may be assimilated to a R binder as evidenced by the similarity of some of its chemical and immunological properties: reactivity with an antihuman R binder antiserum, with the same molecular weight as that of saliva, gastric juice, and bile R binder.
Our results indicate, however, that the pattern of cobalamin-R binder alterations caused by duodenal juice seem to depend on the source of R binder.
Duodenal juice as well as pure trypsin released cobalamin and intact R binder when chicken serum was used as substrate, so that it seems that only the cobalamin binding site is affected. It cannot be excluded, however, that proteolytic fragments would be also produced, although undetectable in our technical conditions, if they cannot bind (57Co) cyanocobalamin. In any case, the percentage of cobalamin released from the chicken binder was significantly decreased in pancreatic insufficiency, compared with controls and there was no overlap between the two groups. The lowest percentage of cobalamin released from chicken serum was observed in patient 3 who presented the greatest degree of steatorrhea. In addition, a malabsorption of both forms of cobalamin was present in this patient. A decreased release of free cobalamin was also observed when normal duodenal juice was collected on aprotinin. The values were close to those observed in pancreatic insufficiency. The presence of intact chicken serum binder shows that this binder is quite resistant to the action of trypsin. This has also been observed with other human R binders. 16 17 Duodenal juice also affected salivary R binders cobalamin complexes but in a different way. Our data show that the saliva R binder was split into smaller fragments. Similar observations have been reported by other investigators using proteolytic enzymes2 or pure human pancreatic juice. '6 In the controls of our study, duodenal juice degraded R binder into one fragment of 60 000 and free cobalamin, approximatively in the same proportions. In pancreatic insufficiency, the degradation was more heterogeneous according to the patients, but in all cases, the proportion of free cobalamin released was significantly reduced. Intact R binder was split into fragments of 60 000 molecular weight as in controls but also into smaller fragments.
Patient 5 in whom the percentage of degraded R salivary was close to that of controls had a normal cobalamin absorption.
Whatever the binder used or whatever the alterations of the cobalamin binder complex induced by duodenal juice, there was a noticeable difference between controls and patients. The percentage of cobalamin released from chicken serum and R saliva and the proportion of degraded fragments from R salivary binder were different in patients with pancreatic insufficiency and in controls. The discrepancy observed between in vitro and in vivo tests, however, frankly perturbed in one and almost always normal in the other suggests that proteolysis by duodenal juice only partly explains the mechanism involved in cobalamin absorption and that other factors are at work notably in pancreatic insufficiency. 
